Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Debt Ratio (2016)

Historic Debt Ratio for Gyre Therapeutics (GYRE) over the last 8 years, with Q3 2016 value amounting to 0.0.

  • Gyre Therapeutics' Debt Ratio fell 9402.06% to 0.0 in Q3 2016 from the same period last year, while for Sep 2016 it was 0.0, marking a year-over-year decrease of 9402.06%. This contributed to the annual value of 0.02 for FY2015, which is N/A changed from last year.
  • Latest data reveals that Gyre Therapeutics reported Debt Ratio of 0.0 as of Q3 2016, which was down 9402.06% from 0.0 recorded in Q2 2016.
  • Gyre Therapeutics' Debt Ratio's 5-year high stood at 0.02 during Q4 2015, with a 5-year trough of 0.0 in Q3 2016.
  • Moreover, its 5-year median value for Debt Ratio was 0.01 (2013), whereas its average is 0.01.
  • As far as peak fluctuations go, Gyre Therapeutics' Debt Ratio skyrocketed by 12039.29% in 2015, and later crashed by 9402.06% in 2016.
  • Quarter analysis of 5 years shows Gyre Therapeutics' Debt Ratio stood at 0.01 in 2012, then dropped by 25.7% to 0.01 in 2013, then crashed by 47.14% to 0.0 in 2014, then surged by 303.95% to 0.02 in 2015, then plummeted by 96.74% to 0.0 in 2016.
  • Its Debt Ratio was 0.0 in Q3 2016, compared to 0.0 in Q2 2016 and 0.0 in Q1 2016.